Home The Word Brain	My Amedeo FAQ Privacy About
	C49 + CC Journal Club For more information, please refer to our special emails from April 13 and May 19.

Cervical Cancer

Free Subscription 28.04.2025 1 Acta Biochim Biophys Sin (Shanghai) 1 Am J Obstet Gynecol 1 Anal Cell Pathol (Amst) 1 Ann Surg Oncol 1 Arch Pathol Lab Med 1 Belitung Nurs J 1 Bioengineered 1 BMC Cancer 1 BMC Health Serv Res 1 BMC Public Health 2 BMC Womens Health 1 BMJ Open 1 Br J Radiol 1 Brachytherapy 1 Cancer Biother Radiopharm 2 Cancer Control 1 Cancer Invest 1 Case Rep Oncol 1 Cell Death Dis 1 Cell Death Discov 1 Chem Biodivers 1 Cien Saude Colet 1 Crit Rev Oncol Hematol 1 Cureus 1 Cytopathology 1 Ecancermedicalscience 1 Eur J Cancer 1 Eur J Public Health 1 F1000Res 1 Front Genet 5 Front Immunol 1 Front Med (Lausanne) 2 Front Oncol 1 Glob Health Action 2 Gynecol Oncol 1 Health Promot Int 1 Hum Pathol 1 Int J Cancer 1 Int J Clin Oncol 2 Int J Gynaecol Obstet 1 Int J Gynecol Cancer 3 Int J Gynecol Pathol 1 Int J Radiat Oncol Biol Phys 1 J Am Soc Cytopathol 1 J Cancer Policy 1 J Gynecol Oncol 4 J Obstet Gynaecol Res 1 J Palliat Med 1 Jpn J Clin Oncol 1 Med Sci Monit 1 Medicine (Baltimore) 1 Nat Commun 2 PLoS One 2 Sci Rep 1 Steroids 1 Tissue Cell 1 Trop Life Sci Res 2 Vaccine 1 Vaccines (Basel) 1 Virol J 1 World J Surg Oncol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Biochim Biophys Sin (Shanghai)

1. WANG B, Li L, Wu Z, Qian X, et al
   Long noncoding RNA UCA1 knockdown inhibits cisplatin-resistant cervical cancer tumorigenesis via the miR-195-5p/IKBKB axis.
   Acta Biochim Biophys Sin (Shanghai). 2025 Apr 22. doi: 10.3724/abbs.2025032.
   PubMed         Abstract available
   
   

   
   Am J Obstet Gynecol

2. MADHUKARAN S, Fomina YY, Mahendroo M
   Cervical function in pregnancy and disease: new insights from single-cell analysis.
   Am J Obstet Gynecol. 2025;232.
   PubMed         Abstract available
   
   

   
   Anal Cell Pathol (Amst)

3. HOSSEINI SF, Jalali Nadoushan M, Fekrirad Z, Rasooli I, et al
   Omp34-Mediated Acinetobacter baumannii Invasion of Human Cervical Carcinoma Epithelial, HeLa Cells, and the Influence of Anti-Omp34 Antibodies.
   Anal Cell Pathol (Amst). 2025;2025:1931119.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

4. TANG X, Yang B, Bian W, Li K, et al
   A Multicenter Study on the Relationship of Tumor Lesion Location with Bilateral Parametrial Involvement and Pelvic Lymph Node Metastasis in Cervical Squamous Cell Carcinoma.
   Ann Surg Oncol. 2025;32:3449-3457.
   PubMed         Abstract available
   
   

   
   Arch Pathol Lab Med

5. TONG TRS
   Cervical Cancer Screening by Human Papillomavirus Testing of Vulvar Swabs.
   Arch Pathol Lab Med. 2025;149:395.
   PubMed        
   
   

   
   Belitung Nurs J

6. WANG F, Hengudomsub P, Chantamit-O-Pas C
   Factors related to stigma among patients with cervical cancer having chemotherapy after surgery in China: A cross-sectional study.
   Belitung Nurs J. 2025;11:194-204.
   PubMed         Abstract available
   
   

   
   Bioengineered

7. 
   Statement of Retraction: The LOXL1 antisense RNA 1 (LOXL1-AS1)/microRNA-423-5p (miR-423-5p)/ectodermal-neural cortex 1 (ENC1) axis promotes cervical cancer through the mitogen-activated protein kinase (MEK)/extracellular signal-regulated kinase (ERK)
   Bioengineered. 2025;16:2496006.
   PubMed        
   
   

   
   BMC Cancer

8. KHIARI H, Abdelfatteh YB, Mahjoub N, Mekni K, et al
   Trends and projections in cervical cancer incidence in northern Tunisia (1994-2040).
   BMC Cancer. 2025;25:739.
   PubMed         Abstract available
   
   

   
   BMC Health Serv Res

9. BAUTISTA-GONZALEZ E, Quintero Leyra A, Munoz Rocha TV, Reyes-Garcia HT, et al
   Assessing disparities in cancer resources distribution in Mexico.
   BMC Health Serv Res. 2025;25:564.
   PubMed         Abstract available
   
   

   
   BMC Public Health

10. CSANADI M, Filipi K, Ylli A, Dedja B, et al
    Barriers of organized cervical cancer screening in Albania and Montenegro.
    BMC Public Health. 2025;25:1533.
    PubMed         Abstract available
    
    

    
    BMC Womens Health

11. ALHUDHUD M, Maqsood S, Hussein ME, Shaheen R, et al
    Cervical cancer screening: a comparative study of TruScreen vs. Pap Smear.
    BMC Womens Health. 2025;25:198.
    PubMed         Abstract available
    
    
12. SVENSGAARD SNH, Tranberg M, Andersen B, Petersen LK, et al
    Improving cervical cancer screening participation by introducing HPV vaginal self-sampling to women living with HIV in Denmark- a pilot study.
    BMC Womens Health. 2025;25:202.
    PubMed         Abstract available
    
    

    
    BMJ Open

13. HERZIG VAN WEES S, Bakare AA, Akinsola KO, Salako J, et al
    Building HPV vaccine confidence through codesigned interventions with and for healthcare workers in Nigeria: protocol for a pilot cluster randomised controlled trial.
    BMJ Open. 2025;15:e098308.
    PubMed         Abstract available
    
    

    
    Br J Radiol

14. PENG Q, Fan P, Wang X, Tao F, et al
    The impact of plan complexity on dose delivery deviations resulting from multileaf collimator positioning errors in volumetric modulated arc therapy.
    Br J Radiol. 2025;98:785-792.
    PubMed         Abstract available
    
    

    
    Brachytherapy

15. SMALL C, Ortiz S, Bedi M, Joyner M, et al
    How do you do it?: Gynecologic brachytherapy best practices at high volume institutions within the United States and Canada.
    Brachytherapy. 2025;24:365-370.
    PubMed         Abstract available
    
    

    
    Cancer Biother Radiopharm

16. YADAGIRI U, Shaik R, Kolure R, Fatima T, et al
    Immunotherapeutics in Clinical Trials for Cervical Cancer.
    Cancer Biother Radiopharm. 2025 Apr 22. doi: 10.1089/cbr.2025.0031.
    PubMed         Abstract available
    
    

    
    Cancer Control

17. ANG JX, Tay SK
    Comparison of Clinical Efficacy of Liquid-Based Cytology and High-Risk Human Papillomavirus Testing With Partial Genotyping in Cervical Screening of Women Below 30 Years Old.
    Cancer Control. 2025;32:10732748251336414.
    PubMed         Abstract available
    
    
18. HAKIM RU, Amin T, Ul Islam SMB
    Advances and Challenges in Cervical Cancer: From Molecular Mechanisms and Global Epidemiology to Innovative Therapies and Prevention Strategies.
    Cancer Control. 2025;32:10732748251336415.
    PubMed         Abstract available
    
    

    
    Cancer Invest

19. HOMAEI SHANDIZ F, Arastouei S, Hosseini S, Prasad Giri I, et al
    Capecitabine-Enhanced Brachytherapy in Locally Advanced Cervical Cancer: A Phase II Non-Randomized Trial on Safety and Efficacy.
    Cancer Invest. 2025 Apr 23:1-13. doi: 10.1080/07357907.2025.2493238.
    PubMed         Abstract available
    
    

    
    Case Rep Oncol

20. LIU ZP, Liu SH, Zhao H, Ruan FY, et al
    Pathologically Complete Response to Camrelizumab and Apatinib in Advanced Cervical Cancer with PTEN, PIK3CA, MTOR, and ARID1A Mutations: A Case Report.
    Case Rep Oncol. 2025;18:480-492.
    PubMed         Abstract available
    
    

    
    Cell Death Dis

21. ZHANG W, Zhao J, Fan X, Chen S, et al
    Targeted demethylation of the EphA7 promoter inhibits tumorigenesis via the SP1/DNMT1 and PI3K/AKT axes and improves the response to multiple therapies in cervical cancer.
    Cell Death Dis. 2025;16:324.
    PubMed         Abstract available
    
    

    
    Cell Death Discov

22. WANG Y, Ji H, Yang T, Liu Y, et al
    HSP90 regulates dCK stability and inhibits ionizing radiation-induced ferroptosis in cervical cancer cells.
    Cell Death Discov. 2025;11:191.
    PubMed         Abstract available
    
    

    
    Chem Biodivers

23. SUN H, Liang Z, Zang Y, Liu S, et al
    Transcriptome analysis reveals possible antitumor mechanism of intracellular polysaccharide from Phaeodactylum tricornutum on cervical cancer HeLa cells.
    Chem Biodivers. 2025 Apr 19:e202402779. doi: 10.1002/cbdv.202402779.
    PubMed         Abstract available
    
    

    
    Cien Saude Colet

24. SANTOS MAPD, Macedo HKS, Bezerra HS, Medeiros AA, et al
    Access to pap smear among black women compared to other racial/ethnic groups: a systematic review with meta-analysis.
    Cien Saude Colet. 2025;30:e01852023.
    PubMed         Abstract available
    
    

    
    Crit Rev Oncol Hematol

25. CHEN B, Gao J, Sun H, Chen Z, et al
    Surface-Enhanced Raman Scattering (SERS) combined with machine learning enables accurate diagnosis of cervical cancer: from molecule to cell to tissue level.
    Crit Rev Oncol Hematol. 2025 Apr 17:104736.
    PubMed         Abstract available
    
    

    
    Cureus

26. MORITA C, Fujii Y, Maemura S, Yasuda T, et al
    Late Bladder Rupture and Strangulated Ileus Following Radical Hysterectomy and Radiation Therapy for Cervical Cancer.
    Cureus. 2025;17:e81016.
    PubMed         Abstract available
    
    

    
    Cytopathology

27. ASSUNCAO LD, Discacciati MG, da Silva AG, Yoshida A, et al
    Clinical Performance of a Liquid Preservation Medium for Cervicovaginal Samples in DNA-HPV Testing and Liquid-Based Cytology for Cervical Cancer Screening.
    Cytopathology. 2025 Apr 23. doi: 10.1111/cyt.13495.
    PubMed         Abstract available
    
    

    
    Ecancermedicalscience

28. JOHN-OLABODE SO, Udenze IC, Adejimi AA, Ajie O, et al
    Association between tumour necrosis factor-a polymorphism and cervical cancer in Lagos State, Nigeria.
    Ecancermedicalscience. 2025;19:1845.
    PubMed         Abstract available
    
    

    
    Eur J Cancer

29. ONAL C, Elmali A, Demirhan B, Guler OC, et al
    Letter comments on: "Induction chemotherapy followed by chemoradiation in locally advanced cervical cancer: Quality of life outcomes of the GCIG INTERLACE trial".
    Eur J Cancer. 2025 Apr 22:115448. doi: 10.1016/j.ejca.2025.115448.
    PubMed        
    
    

    
    Eur J Public Health

30. NEDOVIC VUKOVIC M, Barjaktarovic Labovic S, Jaksic M, Vuckovic L, et al
    Cervical cancer mortality trend in Montenegro-1990-2018.
    Eur J Public Health. 2025 Apr 23:ckaf059. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    F1000Res

31. KRISHNA A, N V, Shada F, Ms P, et al
    Pre-treatment blood parameters as an economical predictive marker for predicting treatment response in locally advanced cervical cancer.
    F1000Res. 2025;14:118.
    PubMed         Abstract available
    
    

    
    Front Genet

32. NING L, Li X, Xu Y, Si Y, et al
    Immunogenic cell death genes in single-cell and transcriptome analyses perspectives from a prognostic model of cervical cancer.
    Front Genet. 2025;16:1532523.
    PubMed         Abstract available
    
    

    
    Front Immunol

33. JIN G, Wang J
    Both complete response and long-term survival after combination therapy with toripalimab in a patient with meta-oligometastases cervical cancer: a case report.
    Front Immunol. 2025;16:1542795.
    PubMed         Abstract available
    
    
34. ZHANG H, Zhou Z, Wang J, Wang S, et al
    Adverse drug reaction assessment of pembrolizumab in cervical cancer treatment: a real-world pharmacovigilance study using the FAERS database.
    Front Immunol. 2025;16:1582050.
    PubMed         Abstract available
    
    
35. ZENG J, Yin R
    Rethinking treatment approaches for FIGO stage IVB cervical cancer: personalized strategies and emerging therapies.
    Front Immunol. 2025;16:1567296.
    PubMed        
    
    
36. CHEN Z, Zhao B
    The role of tumor-associated macrophages in HPV induced cervical cancer.
    Front Immunol. 2025;16:1586806.
    PubMed         Abstract available
    
    
37. WANG Z, Cheng L, Li G, Cheng H, et al
    Epithelial and macrophage cell interaction in cervical cancer through single-cell RNA-sequencing and spatial analysis.
    Front Immunol. 2025;16:1537785.
    PubMed         Abstract available
    
    

    
    Front Med (Lausanne)

38. HUANG Q, Su W, Li S, Lin Y, et al
    A bibliometric analysis of artificial intelligence applied to cervical cancer.
    Front Med (Lausanne). 2025;12:1562818.
    PubMed         Abstract available
    
    

    
    Front Oncol

39. ZHAO X, Hou S, Hao R, Zang Y, et al
    Prognostic significance of circulating tumor DNA detection and quantification in cervical cancer: a systematic review and meta-analysis.
    Front Oncol. 2025;15:1566750.
    PubMed         Abstract available
    
    
40. YANG Y, Zhu X, Sun D, Fan J, et al
    Lnc-CNNM3-DT as a protective factor in cervical cancer: regulation of LIAS expression and intracellular copper levels.
    Front Oncol. 2025;15:1571788.
    PubMed         Abstract available
    
    

    
    Glob Health Action

41. MADSEN KG, Mosgaard JS, Oshosen M, Swai P, et al
    Barriers and facilitators for implementation of HPV-based cervical cancer screening in Tanzania: a qualitative study among healthcare providers, stakeholders, and Tanzanian women.
    Glob Health Action. 2025;18:2491852.
    PubMed         Abstract available
    
    

    
    Gynecol Oncol

42. LEATH CA 3RD, Deng W, Mell LK, Richardson DL, et al
    Incorporation of triapine (T) to cisplatin chemoradiation (CRT) for locally advanced cervical and vaginal cancer: Results from NRG-GY006, a phase III randomized trial.
    Gynecol Oncol. 2025;195:122-133.
    PubMed         Abstract available
    
    
43. FRIEDMAN EL, Guo XM, Furey KB, Lee AJ, et al
    Temporal trends of sentinel lymph node biopsy without lymphadenectomy at cervical cancer surgery.
    Gynecol Oncol. 2025;196:182-191.
    PubMed         Abstract available
    
    

    
    Health Promot Int

44. YAMADA Y, Okuhara T, Yokota R, Furukawa E, et al
    Evaluating the understandability and actionability of Japanese human papillomavirus vaccination educational materials on cervical cancer.
    Health Promot Int. 2025;40:daaf034.
    PubMed         Abstract available
    
    

    
    Hum Pathol

45. ZHANG Z, Shi H, Shao Y, Lu B, et al
    Clinicopathologic and molecular characterization of primitive neuroectodermal tumors (PNET) in the female genital tract: a retrospective study of 8 cases.
    Hum Pathol. 2025;157:105769.
    PubMed         Abstract available
    
    

    
    Int J Cancer

46. HARPER DM, Paczos T, Ridder R, Huh WK, et al
    p16/ki-67 dual stain triage of individuals positive for HPV to detect cervical precancerous lesions.
    Int J Cancer. 2025 Feb 4. doi: 10.1002/ijc.35353.
    PubMed         Abstract available
    
    

    
    Int J Clin Oncol

47. TAGUCHI T, Yokoyama M, Fujita T, Tanba S, et al
    Utility of circulating human papillomavirus DNA as a biomarker for detection and prognosis of cervical cancer in Japanese patients.
    Int J Clin Oncol. 2025 Apr 21. doi: 10.1007/s10147-025-02762.
    PubMed         Abstract available
    
    

    
    Int J Gynaecol Obstet

48. BIZZARRI N, Kyrgiou M, De Vincenzo R, Zapardiel I, et al
    Prophylactic HPV vaccination in HPV-related gynecologic cancers: European Society of Gynecological Oncology (ESGO) prevention committee opinion.
    Int J Gynaecol Obstet. 2024 Dec 30. doi: 10.1002/ijgo.16120.
    PubMed         Abstract available
    
    
49. MUNGO C, Omoto J, Ogollah C, Owaya A, et al
    Safety and adherence to self-administered intravaginal 5-fluorouracil cream following cervical intraepithelial neoplasia (CIN) 2/3 treatment among HIV-positive women in Kenya: A phase 1 clinical trial.
    Int J Gynaecol Obstet. 2024 Dec 26. doi: 10.1002/ijgo.16093.
    PubMed         Abstract available
    
    

    
    Int J Gynecol Cancer

50. PAVONE M, Baby B, Carles E, Innocenzi C, et al
    Critical view of safety assessment in sentinel node dissection for endometrial and cervical cancer: artificial intelligence to enhance surgical safety and lymph node detection (LYSE study).
    Int J Gynecol Cancer. 2025;35:101789.
    PubMed         Abstract available
    
    

    
    Int J Gynecol Pathol

51. BEN-MUSSA A, Shah R, Rajendran S, McCluggage WG, et al
    A Population-based Study Investigating the Incidence of Human Papillomavirus-Associated and Human Papillomavirus-Independent Cervical Adenocarcinomas.
    Int J Gynecol Pathol. 2025;44:249-254.
    PubMed         Abstract available
    
    
52. NGUYEN DT, Waring D, Wan KM, Loo C, et al
    Superficial and Invasive Spread of High-grade Squamous Intraepithelial Lesion and Squamous Cell Carcinoma: A Case Report.
    Int J Gynecol Pathol. 2025;44:265-267.
    PubMed         Abstract available
    
    
53. LONG X, Ma X, Xiao W, Lv J, et al
    Clinicopathologic and Genomic Features of Invasive Stratified Mucin-producing Carcinoma of the Uterine Cervix Coexisting With High-grade Squamous Intraepithelial Lesion.
    Int J Gynecol Pathol. 2025;44:268-273.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

54. SUN DS, Gong X, Cheng S, Cao R, et al
    Fully Automated Online Adaptive Radiotherapy Decision Making for Cervical Cancer Using Artificial Intelligence.
    Int J Radiat Oncol Biol Phys. 2025 Apr 17:S0360-3016(25)00379.
    PubMed         Abstract available
    
    

    
    J Am Soc Cytopathol

55. HARINATH L, Elishaev E, Ye Y, Matsko J, et al
    Diagnostic performance of the hologic genius digital diagnostics system for low-grade squamous intraepithelial lesion (LSIL) ThinPrep papanicolaou tests.
    J Am Soc Cytopathol. 2025;14:199-207.
    PubMed         Abstract available
    
    

    
    J Cancer Policy

56. HUNSBERGER KS, Kapp DS, Chan JK, Irwin CM, et al
    Suicide rates of cervical cancer patients in the United States - Who is most at risk? A retrospective study of 69,493 patients.
    J Cancer Policy. 2025;44:100586.
    PubMed         Abstract available
    
    

    
    J Gynecol Oncol

57. JAREEMIT N, Kolaka W, Tiyayon J, Tangjitgamol S, et al
    Risk of CIN2+ in women aged >60 years with abnormal cervical cancer screening: a multicenter retrospective cohort study from the Thai Gynecologic Cancer Society research group.
    J Gynecol Oncol. 2025 Apr 7. doi: 10.3802/jgo.2025.
    PubMed         Abstract available
    
    

    
    J Obstet Gynaecol Res

58. LU M, Luo X, Bu Q, Li P, et al
    Association between low-grade cervical cytology and histological cervical intraepithelial neoplasia concurrent vaginal intraepithelial neoplasia among outpatient colposcopy: A retrospective study.
    J Obstet Gynaecol Res. 2025;51:e16289.
    PubMed         Abstract available
    
    
59. YASUDA M, Katoh T, Miyama Y, Honma T, et al
    Histological classification of uterine cervical adenocarcinomas: Its alteration and current status.
    J Obstet Gynaecol Res. 2025;51:e16287.
    PubMed         Abstract available
    
    
60. INOMATA Y, Kodama K, Maenohara S, Yagi H, et al
    Retrospective analysis of treatment and prognosis for clear cell carcinoma of the uterine cervix: 15-year experience at a single institution.
    J Obstet Gynaecol Res. 2025;51:e16300.
    PubMed         Abstract available
    
    
61. AKIS S, Kabaca C, Purut YE, Keles E, et al
    The persistence of HPV type-specific infections in patients following colposcopic examination: An observational study.
    J Obstet Gynaecol Res. 2025;51:e16301.
    PubMed         Abstract available
    
    

    
    J Palliat Med

62. WALL JA, Bratches RW, Barton WC, Boitano TK, et al
    Specialty Palliative Care Consultation in Patients with Cervical Cancer: Who and Why?
    J Palliat Med. 2025 Apr 23. doi: 10.1089/jpm.2024.0344.
    PubMed         Abstract available
    
    

    
    Jpn J Clin Oncol

63. QU T, Zeng G, Yang J, Tang K, et al
    Sentinel lymph node biopsy mapped with carbon nanoparticle suspensions in patients with cervical cancer: a systematic review and meta-analysis.
    Jpn J Clin Oncol. 2025 Apr 20:hyaf063. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Med Sci Monit

64. MIAZGA W, Tatara T, Gujski M, Pinkas J, et al
    Global Guidelines and Trends in HPV Vaccination for Cervical Cancer Prevention.
    Med Sci Monit. 2025;31:e947173.
    PubMed         Abstract available
    
    

    
    Medicine (Baltimore)

65. LU S, Yang H, Mao P, Chen G, et al
    Vaginal stump rupture due to sexual activity leading to small intestine vaginal hernia and intestinal necrosis in a woman after cervical cancer surgery: A case report.
    Medicine (Baltimore). 2025;104:e41788.
    PubMed         Abstract available
    
    

    
    Nat Commun

66. LIAO J, Moshoeshoe R, Holmes MD, Subramanian SV, et al
    Effect of girls' education on cancer awareness and screening in a natural experiment in Lesotho.
    Nat Commun. 2025;16:3737.
    PubMed         Abstract available
    
    

    
    PLoS One

67. BAASLAND I, Bjorge T, Engesaeter B, Trope A, et al
    Cervical intraepithelial neoplasia grade 1 and long-term risk of progression and treatment.
    PLoS One. 2025;20:e0320739.
    PubMed         Abstract available
    
    
68. MELAKU A, Abebe SN, Haile S
    Utilization of screening services on cervical cancer and associated factors among female health workers in Addis Ababa, Ethiopia.
    PLoS One. 2025;20:e0321662.
    PubMed         Abstract available
    
    

    
    Sci Rep

69. SHABANPOUR M, Taherkhani S, Shoja Z, Eftekhari M, et al
    Lineage analysis of human papillomavirus types 33 and 35 based on E6 gene in cervical samples from Tehran, Iran.
    Sci Rep. 2025;15:13736.
    PubMed         Abstract available
    
    
70. CHAN-ON W, Turinthorn M, Chaiwongkot A, Techawiwattanaboon T, et al
    ANGPTL4 suppresses progression and improves cisplatin sensitivity in cervical cancer.
    Sci Rep. 2025;15:14217.
    PubMed         Abstract available
    
    

    
    Steroids

71. TIMOSHENKO O, Kugaevskaya E, Gureeva T, Morozevich G, et al
    Isoxazolyl steroid blocks the Shh signaling pathway and the expression of MMP-2 and MMP-9 in cervical carcinoma cell lines.
    Steroids. 2025;217:109599.
    PubMed         Abstract available
    
    

    
    Tissue Cell

72. YIN Q, Sun B, Qi X, Wu C, et al
    Anticancer activity of Momordica charantia-derived extracellular vesicle-like particle against cervical cancer.
    Tissue Cell. 2025;95:102897.
    PubMed         Abstract available
    
    

    
    Trop Life Sci Res

73. HIDAYATULLAH A, Widiastuti D, Putra WE, Rifa'i M, et al
    Virtual Screening, Molecular Docking and Molecular Dynamics Simulation of Bioactive Compounds from Various Indonesian Medicinal Plants as Potential Inhibitors of Human Papillomavirus Type 16 E6 Protein in Cervical Cancer Development.
    Trop Life Sci Res. 2025;36:1-24.
    PubMed         Abstract available
    
    

    
    Vaccine

74. DAVIDSON N, Fisher J
    "If I know about it of course I would give my son and daughter", barriers to and enablers of accessing human papillomavirus vaccination among women from refugee and asylum-seeking backgrounds resettling in Melbourne, Australia - A qualitative study.
    Vaccine. 2025;53:127064.
    PubMed         Abstract available
    
    
75. EINARSON TA, Musana E, Balonde J, Lorentzen KB, et al
    Human papillomavirus awareness, vaccination rate, and sociodemographic covariates of vaccination status in a low-income country: A cross-sectional study in the rural Busoga region of Uganda.
    Vaccine. 2025;53:127089.
    PubMed         Abstract available
    
    

    
    Vaccines (Basel)

76. AVILA-AGUERO ML, Ospina-Henao S, Brenes-Chacon H, Espinal-Tejada C, et al
    Human Papilloma Virus Vaccination as a Strategy to Eliminate Cervical Cancer: Challenges and Opportunities.
    Vaccines (Basel). 2025;13:297.
    PubMed         Abstract available
    
    

    
    Virol J

77. LIAO J, Deng S, Shi B, Wang M, et al
    HPV16 E7 inhibits HBD2 expression by down-regulation of ASK1-p38 MAPK pathway in cervical cancer.
    Virol J. 2025;22:109.
    PubMed         Abstract available
    
    

    
    World J Surg Oncol

78. HU Y, Cui M
    Meta-analysis of the diagnostic value of SOX1 methylation in different types of cervical cancer.
    World J Surg Oncol. 2025;23:147.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.